BioGaia AB (publ)

Stockholm Stock Exchange BIOG-B.ST

BioGaia AB (publ) Free Cash Flow Yield on February 03, 2025: 3.44%

BioGaia AB (publ) Free Cash Flow Yield is 3.44% on February 03, 2025, a -2.39% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • BioGaia AB (publ) 52-week high Free Cash Flow Yield is 4.04% on October 23, 2024, which is 17.64% above the current Free Cash Flow Yield.
  • BioGaia AB (publ) 52-week low Free Cash Flow Yield is 2.91% on March 05, 2024, which is -15.34% below the current Free Cash Flow Yield.
  • BioGaia AB (publ) average Free Cash Flow Yield for the last 52 weeks is 3.35%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Loading...
SV Wall Street
Stockholm Stock Exchange: BIOG-B.ST

BioGaia AB (publ)

CEO Ms. Theresa P. Agnew
IPO Date Jan. 3, 2000
Location Sweden
Headquarters Kungsbroplan 3
Employees 222
Sector Consumers Staples
Industries
Description

BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylori–the gastric ulcer bacterium; and low bone density. It offers its products under the BioGaia brand name. BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.

Similar companies

BIOT.ST

Biotage AB (publ)

USD 12.37

-2.86%

PROB.ST

Probi AB (publ)

USD 31.05

0.32%

EKTA-B.ST

Elekta AB (publ)

USD 5.73

-2.84%

SECT-B.ST

Sectra AB (publ)

USD 22.49

-1.31%

CEVI.ST

CellaVision AB (publ)

USD 19.20

-5.48%

StockViz Staff

February 5, 2025

Any question? Send us an email